Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 212.50 -8.33 (3.77%)
Previous Close $220.83    52 Week High $333.65 
Open $215.45    52 Week Low $223.02 
Day High $217.28    P/E 27.21 
Day Low $210.54    EPS $7.81 
Volume 617,826       

(NASDAQ: IONS) Delayed: 56.71 -1.38 (2.38%)
Previous Close $58.09    52 Week High $62.68 
Open $52.15    52 Week Low $19.59 
Day High $57.43    P/E N/A 
Day Low $52.15    EPS $0.00 
Volume 9,175,678